Contrary to enhancing E2, which might have a negative feedback on LH release after menopause and thus depression, DSHH can reduce the LH release after ovary removal, increase CSF monoamine concentrations, and improve the score of horizontal movement and vertical movement effectively in the surgery rats. The gene discussed is PLOD1; the disease is depressive disorder.